UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review

Nutrients, 2020-12, Vol.13 (1), p.135

2020

Link zum Volltext

Verfügbarkeit prüfen

Ultraviolet Irradiation of Skin Alters the Faecal Microbiome Independently of Vitamin D in Mice

Nutrients, 2018-08, Vol.10 (8), p.1069

2018

Link zum Volltext

Verfügbarkeit prüfen

What is in our treasure chest? Australian pharmaceutical benefits scheme availability and criteria for prescribing biologics

Journal of gastroenterology and hepatology, 2018-09, Vol.33 (S3), p.12-13

Ghaly, Simon

2018

Link zum Volltext

Verfügbarkeit prüfen

Iron and vitamin D deficiency in inflammatory bowel disease

Journal of gastroenterology and hepatology, 2016-06, Vol.31 (S1), p.27-28

Ghaly, Simon

2016

Link zum Volltext

Verfügbarkeit prüfen

Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study

BMJ open, 2021-02, Vol.11 (2), p.e042493

2021

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D metabolites are lower with active Crohn’s disease and spontaneously recover with development of remission

Therapeutic advances in gastroenterology, 2019-07, Vol.12, p.1756284819865144-1756284819865144

2019

Link zum Volltext

Verfügbarkeit prüfen

The role of vitamin D in gastrointestinal inflammation

Expert review of gastroenterology & hepatology, 2014-11, Vol.8 (8), p.909-923

2014

Link zum Volltext

Verfügbarkeit prüfen

Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial

The lancet. Gastroenterology & hepatology, 2022-02, Vol.7 (2), p.141-151

2022

Link zum Volltext

Verfügbarkeit prüfen

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease

World journal of gastroenterology : WJG, 2022-06, Vol.28 (23), p.2597-2608

2022

Link zum Volltext

Verfügbarkeit prüfen

Mo1835 DOSE ESCALATED INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1135-S-1135

2024

Link zum Volltext

Verfügbarkeit prüfen

Su1841 VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-839-S-839

2024

Link zum Volltext

Verfügbarkeit prüfen

Su1874 THE BURDEN OF MENTAL HEALTH DISEASE IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-854-S-855

2024

Link zum Volltext

Verfügbarkeit prüfen

Mo1833 DOSE ESCALATED USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1134-S-1135

2024

Link zum Volltext

Verfügbarkeit prüfen

Tu1891 THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1456-S-1457

2024

Link zum Volltext

Verfügbarkeit prüfen

Mo1834 DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1135-S-1135

2024

Link zum Volltext

Verfügbarkeit prüfen

Effects of UVR exposure on the gut microbiota of mice and humans

Photochemical & photobiological sciences, 2020-01, Vol.19 (1), p.2-28

2020

Link zum Volltext

Verfügbarkeit prüfen

Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study

Medical journal of Australia, 2021-02, Vol.214 (3), p.128-133

2021

Link zum Volltext

Verfügbarkeit prüfen

Sa1891 HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-467-S-468

2020

Link zum Volltext

Verfügbarkeit prüfen

High Dose Vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitis

Scientific reports, 2018-07, Vol.8 (1), p.11511-12, Article 11511

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial

Clinical gastroenterology and hepatology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure

Alimentary pharmacology & therapeutics, 2018-12, Vol.48 (11-12), p.1328-1330

2018

Link zum Volltext

Verfügbarkeit prüfen

Pericardial Mesothelioma in a 35-Year-Old Male With Ulcerative Colitis

Circulation. Cardiovascular imaging, 2019-12, Vol.12 (1), p.e008659-e008659

2019

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome

Expert review of gastroenterology & hepatology, 2019-11, Vol.13 (11), p.1039-1048

2019

Link zum Volltext

Verfügbarkeit prüfen

Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford

World journal of gastroenterology : WJG, 2020-08, Vol.26 (30), p.4428-4441

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

The Role of Diet in the Pathogenesis and Management of Inflammatory Bowel Disease: A Review

Ultraviolet Irradiation of Skin Alters the Faecal Microbiome Independently of Vitamin D in Mice

What is in our treasure chest? Australian pharmaceutical benefits scheme availability and criteria for prescribing biologics

Iron and vitamin D deficiency in inflammatory bowel disease

Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study

High Technical Success Rate of Endoscopic Balloon Dilatation Reduces Surgical Requirement for Patients With Stricturing Crohn’s Disease

Vitamin D metabolites are lower with active Crohn’s disease and spontaneously recover with development of remission

The role of vitamin D in gastrointestinal inflammation

Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease

Mo1835 DOSE ESCALATED INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Su1841 VARIATION IN OUTCOMES IN INFLAMMATORY BOWEL DISEASE AT TEN AUSTRALASIAN CENTRES - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Su1874 THE BURDEN OF MENTAL HEALTH DISEASE IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Mo1833 DOSE ESCALATED USTEKINUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Tu1891 THE REAL-WORLD USE OF FIVE-AMINOSALICYLATE (5ASA) TREATMENT FOR ULCERATIVE COLITIS IN AUSTRALIA AND NEW ZEALAND: CROHN'S COLITIS CURE (CCC) DATA INSIGHT'S PROGRAM

Mo1834 DOSE ESCALATED VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE - CROHN'S COLITIS CURE (CCC) DATA INSIGHTS PROGRAM

Effects of UVR exposure on the gut microbiota of mice and humans

Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study

Sa1891 HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE

High Dose Vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitis

Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure

Pericardial Mesothelioma in a 35-Year-Old Male With Ulcerative Colitis

Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome

Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford

Suchergebnisse filtern